The DOI matches its Crossref record; 24 of the 25 references it cites were found in a registry or an index.
Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity
Abstract
The sedative drug thalidomide ([+]-alpha-phthalimidoglutarimide), once abandoned for causing birth defects in humans, has found new therapeutic license in leprosy and other diseases, with renewed teratological consequences. Although the mechanism of teratogenesis and determinants of risk remain unclear, related teratogenic xenobiotics are bioactivated by embryonic prostaglandin H synthase (PHS) to a free-radical intermediates that produce reactive oxygen species (ROS), which cause oxidative damage to DNA and other cellular macromolecules. Similarly, thalidomide is bioactivated by horseradish peroxidase, and oxidizes DNA and glutathione, indicating free radical-mediated oxidative stress. Furthermore, thalidomide teratogenicity in rabbits is reduced by the PHS inhibitor acetylsalicylic acid, indicating PHS-catalyzed bioactivation. Here, we show in rabbits that thalidomide initiates embryonic DNA oxidation and teratogenicity, both of which are abolished by pre-treatment with the free radical spin trapping agent alpha-phenyl-N-t-butylnitrone (PBN). In contrast, in mice, a species resistant to thalidomide teratogenicity, thalidomide does not enhance DNA oxidation, even at a dose 300% higher than that used in rabbits, providing insight into an embryonic determinant of species-dependent susceptibility. In addition to their therapeutic implications, these results constitute direct evidence that the teratogenicity of thalidomide may involve free radical-mediated oxidative damage to em…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“They may cause direct cytotoxicity by inducing free radical mediated DNA damage.80”
From Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management (2024) · cites this paper as [80]
Citations
Cites
8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G-T and A-C substitutions.
Cheng, K. C., Cahill, D. S., Kasai, H., Nishimura, S., & Loeb, L. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48474-8 · Cited by 1,844
A short history of thalidomide embryopathy
Lenz, W. (1988) · Teratology · doi:10.1002/tera.1420380303 · Cited by 784
Biochemical Toxicology of Chemical Teratogenesis
Wells, P. G., & Winn, L. M. (1996) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239609110574 · Cited by 160
Self-citationThalidomide teratogenesis: evidence for a toxic arene oxide metabolite.
Gordon, G., Spielberg, S. P., Blake, D. A., & Balasubramanian, V. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.4.2545 · Cited by 153
Schumacher, H., Smith, R. L., & Williams, R. T. (1965) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1965.tb02054.x · Cited by 144
Winn, L. M., & Wells, P. G. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00340-1 · Cited by 114
Self-citationProposed mechanisms of action in thalidomide embryopathy
Stephens, T. D. (1988) · Teratology · doi:10.1002/tera.1420380307 · Cited by 111
Maternal administration of superoxide dismutase and catalase in phenytoin teratogenicity1
Winn, L. M., & Wells, P. G. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00193-2 · Cited by 102
Self-citationFree Radical Intermediates of Phenytoin and Related Teratogens
Parman, T., Chen, G., & Wells, P. G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.39.25079 · Cited by 93
Self-citationCharacterization of a novel cytochrome P450 from the transformable cell line, C3H/10T1/2
Pottenger, L. H., & Jefcoate, C. R. E. (1990) · Carcinogenesis · doi:10.1093/carcin/11.2.321 · Cited by 88
Functional cytochrome P4503A isoforms in human embryonic tissues: expression during organogenesis.
Yang, H., Lee, Q. P., Rettie, A. E., & Juchau, M. R. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09834-7 · Cited by 86
Liu, L., & Wells, P. G. (1995) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(95)00082-9 · Cited by 72
Self-citationTeratogen metabolism: Thalidomide activation is mediated by cytochrome P-450
Braun, A. G., Harding, F., & Weinreb, S. L. (1986) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(86)90449-7 · Cited by 68
Cytochrome P450 in Human Fetal Liver: Significance and Fetal-Specific Expresson
Kitada, M., & Kamataki, T. (1994) · Drug Metabolism Reviews · doi:10.3109/03602539409029800 · Cited by 63
Valproic acid-induced changes in gene expression during neurulation in a mouse model
Wlodarczyk, B. J., Craig, J. C., Bennett, G. D., Calvin, J. A., & Finnell, R. H. (1996) · Teratology · doi:10.1002/(sici)1096-9926(199612)54:6<273::aid-tera1>3.0.co;2-# · Cited by 61
Arlen, R. R., & Wells, P. G. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13119-4 · Cited by 48
Self-citationThalidomide: lack of mutagenic activity across phyla and genetic endpoints
Ashby, J., Tinwell, H., Callander, R. D., Kimber, I., Clay, P., Galloway, S. M., Hill, R., Greenwood, S. K., Gaulden, M. E., Ferguson, M. J., et al. (1997) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(97)00174-7 · Cited by 35
Kim, P. M., & Wells, P. G. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08685-7 · Cited by 31
Self-citationHatfill, S. J., Fester, E., de Beer, D. P., & Böhm, L. (1991) · Leukemia Research · doi:10.1016/0145-2126(91)90093-9 · Cited by 28
Wells, P. G., Kim, P. M., Nicol, C. J. B., Parman, T., & Winn, L. M. (1997) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-60445-4_17 · Cited by 26
Self-citationRelationship between teratogeny and structure in the thalidomide field
Wuest, H. M., Fox, R. R., & Crary, D. D. (1968) · Cellular and Molecular Life Sciences · doi:10.1007/bf02138700 · Cited by 24
Interaction of [Glutarimide-2-14C]thalidomide with rat embryonic DNA in vivo
Huang, P. H. T., & McBride, W. G. (1997) · Teratogenesis Carcinogenesis and Mutagenesis · doi:10.1002/(sici)1520-6866(1997)17:1<1::aid-tcm2>3.0.co;2-l · Cited by 23
Never-ending tales of the mode of the teratogenic action of thalidomide
Neubert, D. (1997) · Teratogenesis Carcinogenesis and Mutagenesis · doi:10.1002/(sici)1520-6866(1997)17:1<i::aid-tcm1>3.0.co;2-l · Cited by 12
Research works printed but not linked: 1
- Arlen, R.R. & Wells, P.G. Extracellular thiol-disulfide status reflecting chemical toxicity mediated via oxidative stress: Validation with paraquat and t-butylhydroperoxide and implications for phenytoin and thalidomide teratogenicity. FASEB J. 4, A608 (1990).
Cited by
Identification of a Primary Target of Thalidomide Teratogenicity
Ito, T., Ando, H., Suzuki, T., Ogura, T., Hotta, K., Imamura, Y., Yamaguchi, Y., & Handa, H. (2010) · Science · doi:10.1126/science.1177319 · Cited by 2,136
Role of oxidative stress in female reproduction
Agarwal, A., Gupta, S., & Sharma, R. K. (2005) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-3-28 · Cited by 1,729
Complexities of CD28/B7: CTLA-4 Costimulatory Pathways in Autoimmunity and Transplantation
Salomon, B., & Bluestone, J. A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.225 · Cited by 1,006
Thalidomide-induced Teratogenesis: History and Mechanisms
Vargesson, N. (2015) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.21096 · Cited by 912
Multiple myeloma: 2022 update on diagnosis, risk stratification, and management
Rajkumar, S. V. (2022) · American Journal of Hematology · doi:10.1002/ajh.26590 · Cited by 883
Metadata
- Authors
- Parman, T., Wiley, M. J., & Wells, P. G.
- Affiliations
- University of Toronto (CA)
- Corresponding author
- Wells, Peter G.
- ORCID
- Wells, Peter G.
- Venue
- Nature Medicine
- Published
- 1999-05
- Volume
- 5
- Issue
- 5
- Pages
- 582-585
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- DOI
- 10.1038/8466
- OpenAlex
- W1568733499
- Semantic Scholar
- 584f5e94f837063f4ceb1b3ddec9c4c9c9ed44ff
- Cited by
- 495
- References
- 25
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 11 · 2023: 2 · 2022: 10 · 2021: 12 · 2020: 10 · 2019: 14 · 2018: 14 · 2017: 10 · 2016: 18 · 2015: 19 · 2014: 13 · 2013: 19 · 2012: 19
- FWCI
- 32.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- thalidomide, teratogenicity, oxidative DNA damage, free radicals, reactive oxygen species, prostaglandin H synthase, horseradish peroxidase, glutathione oxidation, spin trapping, aspirin, embryonic development, congenital malformations
- MeSH terms
- Animals, Cyclic N-Oxides, DNA Damage, Drug Resistance, Embryo, Mammalian, Female, Free Radicals, Hernia, Umbilical, Hypnotics and Sedatives, Nitrogen Oxides, Oxidation-Reduction, Pregnancy, Rabbits, Species Specificity, Teratogens, Thalidomide, Free Radical Scavengers, Limb Deformities, Congenital, Embryo Loss, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.